Pro Share Advisors LLC Neogenomics Inc Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 26,614 shares of NEO stock, worth $385,903. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,614
Previous 19,619 35.65%
Holding current value
$385,903
Previous $272,000 44.12%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$13.4 - $17.73 $93,733 - $124,021
6,995 Added 35.65%
26,614 $392,000
Q2 2024

Aug 13, 2024
SELL
$13.01 - $15.77 $78,892 - $95,629
-6,064 Reduced 23.61%
19,619 $272,000
Q1 2024

May 08, 2024
BUY
$14.06 - $16.79 $24,815 - $29,634
1,765 Added 7.38%
25,683 $403,000
Q4 2023

Feb 14, 2024
BUY
$11.67 - $20.73 $52,818 - $93,823
4,526 Added 23.34%
23,918 $386,000
Q3 2023

Nov 13, 2023
SELL
$12.15 - $17.85 $6,232 - $9,157
-513 Reduced 2.58%
19,392 $238,000
Q2 2023

Aug 10, 2023
BUY
$14.1 - $19.83 $23,180 - $32,600
1,644 Added 9.0%
19,905 $319,000
Q1 2023

May 11, 2023
SELL
$9.09 - $19.45 $14,707 - $31,470
-1,618 Reduced 8.14%
18,261 $317,000
Q4 2022

Feb 02, 2023
BUY
$6.45 - $12.07 $16,634 - $31,128
2,579 Added 14.91%
19,879 $183,000
Q3 2022

Nov 04, 2022
SELL
$7.86 - $12.91 $17,842 - $29,305
-2,270 Reduced 11.6%
17,300 $149,000
Q2 2022

Aug 01, 2022
SELL
$7.06 - $13.97 $62,106 - $122,894
-8,797 Reduced 31.01%
19,570 $159,000
Q1 2022

May 10, 2022
SELL
$12.15 - $35.28 $40,775 - $118,399
-3,356 Reduced 10.58%
28,367 $344,000
Q4 2021

Feb 08, 2022
BUY
$30.49 - $48.49 $338,865 - $538,917
11,114 Added 53.93%
31,723 $1.08 Million
Q3 2021

Nov 12, 2021
SELL
$41.66 - $52.52 $500,461 - $630,922
-12,013 Reduced 36.82%
20,609 $994,000
Q2 2021

Aug 13, 2021
BUY
$36.62 - $51.69 $4,870 - $6,874
133 Added 0.41%
32,622 $1.47 Million
Q1 2021

May 14, 2021
BUY
$41.56 - $59.88 $296,904 - $427,782
7,144 Added 28.19%
32,489 $1.57 Million
Q4 2020

Feb 09, 2021
BUY
$36.08 - $56.47 $384,252 - $601,405
10,650 Added 72.47%
25,345 $1.37 Million
Q3 2020

Nov 13, 2020
SELL
$33.26 - $40.48 $40,743 - $49,587
-1,225 Reduced 7.69%
14,695 $542,000
Q2 2020

Aug 03, 2020
BUY
$24.21 - $31.02 $209,513 - $268,447
8,654 Added 119.1%
15,920 $493,000
Q1 2020

May 15, 2020
SELL
$20.5 - $34.53 $174,824 - $294,471
-8,528 Reduced 54.0%
7,266 $201,000
Q4 2019

Feb 12, 2020
BUY
$18.96 - $29.84 $43,702 - $68,781
2,305 Added 17.09%
15,794 $462,000
Q3 2019

Nov 12, 2019
BUY
$19.12 - $26.24 $35,524 - $48,753
1,858 Added 15.97%
13,489 $258,000
Q2 2019

Aug 13, 2019
SELL
$19.57 - $24.1 $273 - $337
-14 Reduced 0.12%
11,631 $255,000
Q1 2019

May 15, 2019
BUY
$12.14 - $20.46 $141,370 - $238,256
11,645 New
11,645 $238,000

Others Institutions Holding NEO

# of Institutions
291
Shares Held
124M
Call Options Held
698K
Put Options Held
120K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.82B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email